Unilever wins ‘I Can’t Believe It’s Not Butter!’ labeling appeal

By Blake Brittain (Reuters) – Unilever’s “I Can’t Believe It’s Not Butter!” spray is governed by different U.S. Food and Drug Administration regulations than butter and similar products, a U.S. appeals court ruled Tuesday, defeating a long-running false advertising class action. A split 9th Circuit Court of Appeals rejected claims that Unilever based its zero-fat,…

Read More

WhatsApp and other messaging apps oppose UK’s move on encryption

LONDON (Reuters) – WhatsApp and other messaging services have united to oppose Britain’s plan to force tech companies to break end-to-end encryption in private messages in its proposed internet safety legislation. Meta-owned WhatsApp, Signal and five other apps signed an open letter saying the law could give an “unelected official the power to weaken the…

Read More

Crypto firms will develop ‘offshore’ without clear US rules, Coinbase chief says

By Tom Wilson and Elizabeth Howcroft LONDON (Reuters) -The U.S. and Britain should make their rules for the crypto industry much clearer to prevent firms from developing in “offshore havens”, the chief of U.S. crypto exchange Coinbase Global Inc, Brian Armstrong, said on Tuesday. The failure last year of the Bahamas-based FTX exchange has highlighted…

Read More

Dollar slips after upbeat China data; euro, pound rise

By Herbert Lash and Samuel Indyk NEW YORK/LONDON (Reuters) – The dollar fell against most major currencies on Tuesday after better-than-forecast growth data from China, while strong pay figures from Britain supported the pound. China’s gross domestic product (GDP) grew 4.5% year on year in the first three months of the year, data showed, beating…

Read More

AstraZeneca confident new COVID antibody protects against known variants

By Maggie Fick BARCELONA (Reuters) – AstraZeneca is confident that its new version of COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants, its vaccines head said. Laboratory studies show the antibody, called AZD3152, neutralizes all known variants of COVID-19 and AstraZeneca has support from regulators to make the treatment available by…

Read More

GSK bets $2 billion on Bellus cough drug to soothe pipeline fears

By Natalie Grover and Aby Jose Koilparambil (Reuters) -GSK plans to buy Canada-based drug developer Bellus Health Inc in an all-cash deal for $2 billion as the British drugmaker expands its bet on respiratory therapies. The move to replenish its pipeline comes as GSK investors fret about whether there is enough in the medicine cabinet…

Read More

UK regulator probes Amazon’s planned purchase of iRobot

(Reuters) -Britain’s competition regulator said on Tuesday it has launched a “Phase 1” probe into Amazon.com Inc’s planned $1.7 billion acquisition of iRobot Corp, which makes the Roomba vacuum cleaner. The probe launch by the UK watchdog comes at a time antitrust regulators, including those in the U.S. and the European Union, have become increasingly…

Read More

Teck’s base metals business attracts offers from Freeport, Vale, Anglo – sources

By Mrinmay Dey (Reuters) -Teck Resources Ltd has been approached by Vale SA, Anglo American Plc and Freeport-McMoRan Inc among others to explore deals for its base metals business if the Canadian copper miner goes ahead with a planned split, sources close to the matter told Reuters on Sunday. The approaches from more than six…

Read More